Overcoming Challenges to Gene Therapy Manufacturing Workshop
Gene therapy clinical trials pose interesting challenges in GMP manufacturing. Plasmids and vectors often cannot be produced by the same vendors, may have different stabilities, and may require different storage conditions. Furthermore, some gene therapies require additional processing of the vector with target cells ex vivo. This expert-led session will explore innovations and best practices that are shortening timelines, lowering costs, and standardizing processes when manufacturing gene therapies.
Chair:
Anthony Gringeri, Ph.D., Strategic Advisor, Cell One Partners
Speakers:
David Backer, Chief Commercial Officer, Oxford Biomedica
Michelle Berg, President, GMP Nucleic Acids, Aldevron
Fabian Gerlinghaus, Co-Founder and CEO, Cellares
Judith Koliwer, Ph.D., Lead Consultant Software, Körber Business Area Pharma
Видео Overcoming Challenges to Gene Therapy Manufacturing Workshop канала Alliance for Regenerative Medicine
Chair:
Anthony Gringeri, Ph.D., Strategic Advisor, Cell One Partners
Speakers:
David Backer, Chief Commercial Officer, Oxford Biomedica
Michelle Berg, President, GMP Nucleic Acids, Aldevron
Fabian Gerlinghaus, Co-Founder and CEO, Cellares
Judith Koliwer, Ph.D., Lead Consultant Software, Körber Business Area Pharma
Видео Overcoming Challenges to Gene Therapy Manufacturing Workshop канала Alliance for Regenerative Medicine
Показать
Комментарии отсутствуют
Информация о видео
21 января 2022 г. 1:39:07
01:21:38
Другие видео канала
![Gamida Cell](https://i.ytimg.com/vi/PzLuw2REVp4/default.jpg)
![Astellas Pharma](https://i.ytimg.com/vi/m2hfpN6EUYI/default.jpg)
![Workshop: Aligning Clinical, Manufacturing, and Logistics Platforms to Treat Patients at Scale](https://i.ytimg.com/vi/W1i8YjXOQmI/default.jpg)
![PTC Therapeutics](https://i.ytimg.com/vi/Pv8HNQSnc8Y/default.jpg)
![AskBio](https://i.ytimg.com/vi/7o40cDim3n4/default.jpg)
![Featured Fireside Chat: EMA Perspective](https://i.ytimg.com/vi/UDqprhoE1aA/default.jpg)
![AVROBIO](https://i.ytimg.com/vi/1GiBq-weFCY/default.jpg)
![Cell Therapy Treatments for COVID-19](https://i.ytimg.com/vi/WO6c1m8nVDo/default.jpg)
![Aspect Biosystems](https://i.ytimg.com/vi/gHQmifRPB7Y/default.jpg)
![Bone Therapeutics](https://i.ytimg.com/vi/CaXYCyv9JVw/default.jpg)
![Mesoblast](https://i.ytimg.com/vi/qUqjpmA1dFA/default.jpg)
![Senti Biosciences](https://i.ytimg.com/vi/UjWCXEjxW2c/default.jpg)
![Mammoth Biosciences](https://i.ytimg.com/vi/nnuTavmefWs/default.jpg)
![Aspect Biosystems](https://i.ytimg.com/vi/20ec4HWQ3sI/default.jpg)
![Terumo BCT](https://i.ytimg.com/vi/nunMwUKmVdA/default.jpg)
![uniQure](https://i.ytimg.com/vi/ZrWd39PNcqQ/default.jpg)
![Panel: Gene Therapy: Building the Gene Medicine Pipeline Through Next Generation Technologies](https://i.ytimg.com/vi/9OCKqqNYWWg/default.jpg)
![Gene-Based Medicine Development Workshop I](https://i.ytimg.com/vi/AkDtKNg7qrg/default.jpg)
![Panel: Ex Vivo Gene Therapy: Using Stem Cells to Treat Genetic Disorders - Florian Eichler, Harvard](https://i.ytimg.com/vi/-2qr59aRfeE/default.jpg)
![CombiGene](https://i.ytimg.com/vi/IyPrlhndYaY/default.jpg)
![Patient and Public Attitudes Toward Gene Therapy Workshop](https://i.ytimg.com/vi/z2j9sUtdr_8/default.jpg)